Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1999
06/09/1999EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
06/09/1999EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS
06/09/1999EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
06/09/1999EP0920506A1 Human dbi/acbp-like protein
06/09/1999EP0920505A1 Mammalian cell surface antigens; related reagents
06/09/1999EP0920502A1 Methods and means for modifying complement activation
06/09/1999EP0920501A1 Neuritin, a neurogene
06/09/1999EP0920500A1 Human proteolipid
06/09/1999EP0920452A1 Novel osteopontin derived chemotactic peptides and methods of use
06/09/1999EP0920449A2 Peptides
06/09/1999EP0920305A1 Identification of genes altered in multiple myeloma
06/09/1999CN1219203A Process for the preparation of recombinant proteins in e. coli by high cell density fermentation
06/09/1999CA2224256A1 Method for treating established spontaneous auto-immune diseases in mammals
06/08/1999US5910582 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
06/08/1999US5910576 Method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein
06/08/1999US5910575 Monoclonal antibody which binds to (125)i-labeled derivatives of cortisol-3-carboxymethyloxime-histamine and preferentially binds to unlabeled syn isomer over unlabeled anti isomer; for competitive radioimmunoassay
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999US5910573 Monomeric and dimeric antibody-fragment fusion proteins
06/08/1999US5910486 Introducing into a malignant mammalian cell a nucleic acid molecule encoding an antibody homologue intracellularly which binds to an oncoprotein on cell surface to kill the cell
06/08/1999US5910481 Hybrid proteins with modified activity
06/08/1999US5910451 Trophinin and trophinin-assisting proteins
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910426 Protein tyrosine kinase
06/08/1999US5910418 Immunoassay to identify prematurely terminated gene products; diagnosis of familial adenomatous polyposis
06/08/1999US5910417 Controlling allergic inflammation; by administering to humans a compound which interacts with kinase signal tranduction pathway, suppressing cytokine production
06/08/1999US5910416 Adrenomedullin
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens
06/08/1999US5910309 UV-induced factor for immunosuppression
06/08/1999US5910252 Medical device for hemodialysis, ultrafiltration, hemofiltration, and other blood treatments; for automatic performance and monitoring; pumps, replacement fluid supplies, tubes, reservoirs, controllers, computers, instrument panels
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA1340587C Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
06/04/1999CA2253011A1 Dna encoding neospora dihydrofolate reductase-thymidylate synthase
06/03/1999WO1999027366A2 Method of detecting prostate specific antigen activation peptide
06/03/1999WO1999027356A1 Improvements in or relating to electrochemical assays
06/03/1999WO1999027128A1 ribH
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027111A1 Desaturase genes and their use
06/03/1999WO1999027109A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
06/03/1999WO1999027106A1 NOVEL guaA
06/03/1999WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027100A1 Fibroblast growth factor-19
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027096A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999027091A1 Dp transcription factor-interacting protein and its use
06/03/1999WO1999027088A2 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027073A1 deoD
06/03/1999WO1999026980A1 Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
06/03/1999WO1999026970A1 NOVEL pth
06/03/1999WO1999026965A1 Cyclosporine derivatives and uses thereof
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999WO1999026658A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999WO1999026656A1 Monoclonal human natural antibodies
06/03/1999WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999019360A9 Methods for detection of prion protein as an indication of transmissible spongiform encephalopathies
06/03/1999WO1999018996B1 Enterococcus antigens and vaccines
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999015563A9 Catalytic antibodies and a method of producing same
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
06/03/1999WO1999009166A3 Prostate tumor polynucleotide and antigen compositions
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2310805A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999CA2310777A1 Method of detecting prostate specific antigen
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2310217A1 Extracellular matrix-binding proteins from staphylococcus aureus
06/03/1999CA2309897A1 A novel egf motif protein obtained from a cdna library of fetal liver-spleen
06/03/1999CA2309677A1 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999CA2253633A1 Complex specific antibodies, method of preparation and uses thereof
06/02/1999EP0919617A1 Anti-human mp52 monoclonal antibody
06/02/1999EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918871A2 Afc1 and rce1:isoprenylated caax processing enzymes
06/02/1999EP0918870A1 Chitinase materials and methods
06/02/1999EP0918866A1 Anti-herpesviral agent
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918858A1 Common gamma chain blocking agents
06/02/1999EP0918857A1 Human induced tumor protein
1 ... 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 ... 1494